you are here: HomeNewsWorld
Last Updated : Oct 15, 2020 09:10 AM IST | Source:

Coronavirus News | France's Macron to reinstate state of emergency

The move is expected to start from October 17 and will allow the government to enforce stricter measures in the future, either locally or nationally

Associated Press
Emmanuel Macron (REUTERS/Pascal Rossignol)
Emmanuel Macron (REUTERS/Pascal Rossignol)

President Emmanuel Macron's office says France will restore a state of health emergency that expired three months ago.

Macron addressed the nation on television on October 14 night. The move is expected to start from October 17 and will allow the government to enforce stricter measures in the future, either locally or nationally.

Follow our LIVE Updates on the coronavirus pandemic here


France initially declared a state of health emergency in March, paving the way for the government to require citizens to stay home in lockdown.

COVID-19 Vaccine

Frequently Asked Questions

View more
How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.

View more

Patients with COVID-19 occupy a third of intensive care units nationwide. France reported about 180 positive cases per 100,000 people during the last week and higher concentrations in some cities.

France has 798,000 confirmed cases and nearly 33,000 deaths.

Follow our full COVID-19 coverage here
First Published on Oct 15, 2020 09:08 am